Drug Database
Back to search

Belgium· BE-AMP-SAM211093-00

Valtran Retard 50 mg - 4 mg

A tilidine product containing tilidine phosphate, registered in Belgium by Pfizer.

ATC N02AX01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedValtran Retard 50 mg - 4 mgATCN02AX01REGISTER NO.BE-AMP-SAM211093-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tilidine phosphateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tilidine Phosphate
Manufacturer
Pfizer
Country
Belgium (BE)
ATC code
N02AX01
ATC class
Tilidine
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    1682269
  • be_apb
    0769877
  • be_apb
    2086916

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for tilidine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tilidine against other medicinesHow interaction checks work

Tilidine · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under N02AX01

Tilidine, as other registers publish it.

All tilidine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b57c31fd-df2b-471c-920e-a8cb490a19d7
GET /v1/drugs/b57c31fd-df2b-471c-920e-a8cb490a19d7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Valtran Retard 50 mg - 4 mg",
  "name_fr": "Valtran Retard 50 mg - 4 mg",
  "name_nl": "Valtran Retard 50 mg - 4 mg",
  "amp_code": "SAM211093-00",
  "strengths": [
    "59.9300",
    "59.9300",
    "50.0000",
    "50.0000",
    "4.4000",
    "4.4000",
    "4.0000",
    "4.0000",
    "39.9200"
  ],
  "pack_count": 3,
  "substances": [
    "Tilidine Phosphate",
    "Tilidine Hydrochloride",
    "Naloxone Hydrochloride Dihydrate",
    "Naloxone Hydrochloride",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tilidine",
  "authorisation_numbers": [
    "BE211093"
  ]
}
API referenceMCP serverPlans

See everything about tilidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console